Global Wealth Management Investment Advisory’s Oruka Therapeutics ORKA Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2	Closed	–	–	697
2020 Q1	$0	Hold	2	–	–	﹤0.01%	676
2019 Q4	$0	Hold	2	–	–	﹤0.01%	731
2019 Q3	$0	Hold	2	–	–	﹤0.01%	745
2019 Q2	$0	Hold	2	–	–	﹤0.01%	802
2019 Q1	$0	Sell	2 -5	-71%	-$444	﹤0.01%	778
2018 Q4	$1K	Buy	+7	New	+$868	﹤0.01%	684

Other funds holding ORKA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Global Wealth Management Investment Advisory's ORKA Position: Q2 2020 in Review

Global Wealth Management Investment Advisory sold out of Oruka Therapeutics (ORKA) in Q2 2020, closing a stake of 2 shares.

Global Wealth Management Investment Advisory first reported a position in ORKA in Q4 2018 and held it in 6 quarters. The position peaked at $1K in Q4 2018. 8 funds tracked by Wall St. Rank hold ORKA as of Q2 2020.

Global Wealth Management Investment Advisory reported no remaining Oruka Therapeutics position as of Q2 2020 after selling out during the quarter.
Global Wealth Management Investment Advisory sold 2 Oruka Therapeutics shares in Q2 2020.
Global Wealth Management Investment Advisory first reported a position in Oruka Therapeutics in Q4 2018 and held it in 6 quarters.
Global Wealth Management Investment Advisory's Oruka Therapeutics position peaked at $1K in Q4 2018.
8 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q2 2020, filed 12 Aug 2020.